X0306 4 2020-11-01 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001724567 Schultz Kare C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 1 1 0 0 President and CEO Ordinary Shares 2020-11-01 4 M 0 180000 A 270480 D Ordinary Shares 2020-11-03 4 M 0 212314 A 482794 D Restricted Share Units 2020-11-01 4 M 0 180000 0.00 D Ordinary Shares 180000 296389 D Restricted Share Units 2020-11-03 4 M 0 212314 0.00 D Ordinary Shares 212314 0 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on November 3, 2017, with 63,613 vesting on November 3, 2019, 180,000 vesting on each of November 1,2020 and November 1, 2021 and 116,389 vesting on November 1, 2022. Restricted share units were granted on February 11, 2020 pursuant to the satisfaction of performance criteria and vested on November 3, 2020. /s/ Dov Bergwerk as attorney-in-fact of Kare Schultz 2020-11-03